JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

07 5 2025 16:01:25 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: JOURNEY MEDICAL CORPORATION - COMMON STOCK

23 4 2025 09:45:10 提供 NetDania Notify

NetDania - New 12 months High: JOURNEY MEDICAL CORPORATION - COMMON STOCK

22 4 2025 16:02:52 提供 NetDania Notify

NetDania - New 12 months High: JOURNEY MEDICAL CORPORATION - COMMON STOCK

04 4 2025 09:45:28 提供 NetDania Notify

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

01 4 2025 16:01:16 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

26 3 2025 16:01:00 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

24 3 2025 08:30:00 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

19 3 2025 16:01:56 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

12 3 2025 08:30:49 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

05 3 2025 16:01:06 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

04 3 2025 16:01:50 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

23 1 2025 08:30:42 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

12 11 2024 16:01:12 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

04 11 2024 07:00:53 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

25 10 2024 08:30:35 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03 10 2024 08:30:23 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

09 9 2024 08:30:35 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

04 9 2024 08:15:03 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

12 8 2024 16:01:35 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

06 8 2024 16:01:38 提供 Nasdaq GlobeNewswire